Congenital Hyperinsulinism in Brazilian Neonates: A Study of Histology,KATP Channel Genes,and Proliferation of β Cells

Abstract

Congenital hyperinsulinism (CHI) is a rare pancreatic β-cell disease of neonates, characterized by inappropriate insulin secretion with severe persistent hypoglycemia, with regard to which many questions remain to be answered, despite the important acquisition of its molecular mechanisms in the last decade. The aim of this study was to examine pancreatic histology, β-cell proliferation (immunohistochemistry with double staining for Ki-67/insulin), and β-cell adenosine triphosphate-sensitive potassium channels genes from 11 Brazilian patients with severe medically unresponsive CHI who underwent pancreatectomy. Pancreatic histology and β-cell proliferation in CHI patients were compared to pancreatic samples from 19 age-matched controls. Ten cases were classified as diffuse form (D-CHI) and 1 as focal form (F-CHI). β-cell nucleomegaly and abundant cytoplasm were absent in controls and were observed only in D-CHI patients. The Ki-67 labeling index (Ki-67-LI) was used to differentiate the adenomatous areas of the F-CHI case (10.15%) from the “loose cluster of islets” found in 2 D-CHI samples (2.29% and 2.43%) and 1 control (1.54%) sample. The Ki-67-LI was higher in the F-CHI adenomatous areas, but D-CHI patients also had significantly greater Ki-67-LI (mean value = 2.41%) than age-matched controls (mean value = 1.87%) (P = 0.009). In this 1st genetic study of CHI patients in Brazil, no mutations or new polymorphisms were found in the 33–37 exons of the ABCC8 gene (SUR1) or in the entire exon of the KCNJ11 gene (Kir 6.2) in 4 of 4 patients evaluated. On the other hand, enhanced β-cell proliferation seems to be a constant feature in CHI patients, both in diffuse and focal forms.

Keywords

congenital hyperinsulinism KATP channel mutations Kir 6.2,Ki-67/insulin double immunostaining pancreatic β-cells proliferation index SUR1

Get full access to this article

View all access options for this article.

References

Glaser

Landau

Permutt

. Neonatal hyperinsulinism. Trends Endocr Metab 1999;10:55–61.

De Léon

Stanley

. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007;3:57–68.

Dunne

Cosgrove

Shepherd

Aynsley-Green

Lindley

. Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 2004;84:239–275.

Glaser

Chiu

Anker

. Familial hyperinsulinism maps to chromosome 11p14–15.1, 30 cm centromeric to the insulin gene. Nat Genet 1994;7:185–188.

Thomas

Cote

Wohllk

. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426–429.

Thomas

Wohllk

Huang

. Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet 1996;59:510–518.

Thomas

Lightner

. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996;5:1809–1812.

Nestorowicz

Wilson

Schoor

. Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996;5:1813–1822.

Nestorowicz

Inagaki

Tohru

. A nonsense mutation in the inward rectifier potassium channel gene, Kir 6.2, is associated with familial hyperinsulinism. Diabetes 1997;46:1743–1748.

10.

Tornovsky

Crane

Cosgrove

. Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity. J Clin Endocrinol Metab 2004;89:6224–6234.

11.

Thornton

MacMullen

Ganguly

. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Diabetes 2003;52:2403–2410.

12.

Rahier

Sempoux

Fournet

. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycemia: the pathologist's role. Histopathology 1998;32:15–19.

13.

Rahier

Guiot

Sempoux

. Persistent hyperinsulinaemic hypoglycemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 2000;82:108–112.

14.

Sempoux

Guiot

Lefevre

. Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 1998;83:1455–1461.

15.

Sempoux

Guiot

Dubois

. Pancreatic B-cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases. Mod Pathol 1998;11:444–449.

16.

De Lonlay

Fournet

J-C

Touati

. Heterogeneity of persistent hyperinsulinaemic hypoglycemia. A series of 175 cases. Eur J Pediatr 2002;161:37–48.

17.

De Lonlay

Touati

Robert

J-J

Saudubray

J-M

. Persistent hyperinsulinaemic hypoglycemia. Semin Neonatol 2002;7:95–100.

18.

Suchi

Thornton

Adzick

. Congenital hyperinsulinism intraoperative biopsy interpretation can direct the extent of pancreatectomy. Am J Surg Pathol 2004;28:1326–1335.

19.

Verkarre

Fournet

J-C

De Lonlay

. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998;102:1286–1291.

20.

Fournet

J-C

Mayaud

De Lonlay

. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism. Am J Pathol 2001;158:2177–2184.

21.

Sempoux

. Hyperinsulinisme neonatal persistant: lês nouvelles découvertes em pathologie éclairent la pathophysiologie du syndrome et en dirigent l'approche thérapeutique. Bull Mem Acad R Med Bel 2003;158:291–297.

22.

Suchi

MacMullen

Thornton

. Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism. Mod Pathol 2006;19:122–129.

23.

Smith

Malone

Risdon

. Focal or diffuse lesions in persistent hyperinsulinemic hypoglycemia of infancy: concerns about interpretation of intraoperative frozen sections. Pediatr Dev Pathol 2001;4:138–143.

24.

Reinecke-Lüthge

Koschoreck

Klöppel

. The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates. Virch Arch 2000;436:1–5.

25.

Suchi

MacMullen

Thornton

. Histopathology of congenital hyperinsulinism: retrospective study with genotype correlations. Pediatr Dev Pathol 2003;6:322–333.

26.

Ernst

Suchi

Stanley

. Localized islet cell nuclear enlargement in congenital hyperinsulinism: a distinct clinicopathologic entity. Mod Pathol 2007;20:287.

27.

Aguilar-Bryan

Bryan

. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 1999;20:101–135.

28.

Efrat

. Regulation of insulin secretion: insights from engineered β-cell lines. Ann N Y Acad Sci 2004;1014:88–96.

29.

Gloyn

Siddiqui

Ellard

. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir 6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Muta 2006;27:220–231.

30.

Kassem

Ariel

Thornton

Scheimberg

Glaser

. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism ofinfancy. Diabetes 2000;49:1325–1333.

31.

De Lonlay-Debeney

Poggi-Travert

Fournet

J-C

. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999;340:1169–1175.

32.

Bowens

De Krijger

. Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 1997;40:398–404.

33.

Zerbini

Almeida

Wakamatsu

Marujo

Lopes

LHAC

Maksoud

. DNA content and proliferating cell nuclear antigen (PCNA) in persistent neonatal hyperinsulinemic hypoglycemia (PNHH). Mod Pathol 1994;7:149A.

34.

Fournet

Junien

. The genetics of neonatal hyperinsulinism. Horm Res 2003;59(Suppl 1):30–34.